Dormer Laura, Schindler Thomas, Williams Lauri Arnstein, Lobban Dawn, Khawaja Sheila, Hunn Amanda, Ubilla Daniela Luzuriaga, Sargeant Ify, Hamoir Anne-Marie
Future Science Group, London, UK.
Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach a. d. Riss, Germany.
Res Involv Engagem. 2022 Jun 2;8(1):23. doi: 10.1186/s40900-022-00358-6.
Peer-reviewed scientific publications and congress abstracts are typically written by scientists for specialist audiences; however, patients and other non-specialists are understandably interested in the potential implications of research and what they may mean for them. Plain language summaries (PLS)-summaries of scientific articles in easy-to-read language-are emerging as a valuable addition to traditional scientific publications. Co-creation of PLS with the intended audience is key to ensuring a successful outcome, but practical guidance on how to achieve this has been lacking.
Building on the Patient Engagement (PE) Quality Guidance previously developed by Patient Focused Medicines Development (PFMD), a multi-stakeholder working group (WG) of individuals with patient engagement experience and/or expertise in PLS was established to develop further activity-specific guidance. PLS guidance was developed through a stepwise approach that included several rounds of co-creation, public consultation (two rounds), internal review and a final external review. The iterative development process incorporated input from a wide variety of stakeholders (patient representatives, industry members, publishers, researchers, medical communications agencies, and public officials involved in research bodies). Feedback from each step was consolidated by the WG and used for refining the draft guidance. The final draft was then validated through external consultation.
The WG comprised 14 stakeholders with relevant experience in PE and/or PLS. The WG developed a set of 15 ethical principles for PLS development. These include the necessity for objective reporting and the absence of any promotional intent, the need for balanced presentation, the importance of audience focus, the need to apply health literacy principles, and the importance of using inclusive and respectful language. The first public consultation yielded 29 responses comprising 478 comments or edits in the shared draft guidance. The second public consultation was an online survey of 14 questions which had 32 respondents. The final 'How-To' Guide reflects feedback received and provides a rational, stepwise breakdown of the development of PLS.
The resulting 'How-To' Guide is a standalone, practical, ready-to-use tool to support multi-stakeholder co-creation of PLS.
同行评审的科学出版物和会议摘要通常由科学家撰写,面向专业受众;然而,患者和其他非专业人士对研究的潜在影响以及这些影响对他们可能意味着什么感兴趣,这是可以理解的。通俗易懂的语言摘要(PLS)——用易于理解的语言对科学文章进行的总结——正成为传统科学出版物的一项有价值的补充。与目标受众共同创作PLS是确保取得成功的关键,但一直缺乏关于如何实现这一点的实用指导。
基于患者聚焦药物研发(PFMD)先前制定的患者参与(PE)质量指南,成立了一个多利益相关方工作组(WG),其成员具有患者参与经验和/或PLS方面的专业知识,以制定进一步的针对具体活动的指导。PLS指南通过逐步方法制定,包括多轮共同创作、公众咨询(两轮)、内部审查和最终外部审查。迭代式开发过程纳入了来自广泛利益相关方(患者代表、行业成员、出版商、研究人员、医学传播机构以及参与研究机构的政府官员)的意见。工作组汇总了每一步的反馈,并用于完善指南草案。最终草案随后通过外部咨询进行了验证。
工作组由14名在PE和/或PLS方面具有相关经验的利益相关方组成。工作组制定了一套15条PLS开发的伦理原则。这些原则包括客观报告的必要性和不存在任何促销意图、平衡呈现的必要性、关注受众的重要性、应用健康素养原则的必要性以及使用包容性和尊重性语言的重要性。第一次公众咨询收到了29份回复,包括对共享指南草案的478条评论或编辑意见。第二次公众咨询是一项包含14个问题的在线调查,有32名受访者。最终的“操作指南”反映了收到的反馈,并对PLS的开发提供了合理、逐步的详细说明。
最终形成的“操作指南”是一个独立、实用、随时可用的工具,以支持多利益相关方共同创作PLS。